Report of two cases of pseudoprogression in patients with non–small cell lung cancer treated with nivolumab—including histological analysis of one case after tumor regression-Reference-Cited by-同舟云学术

Report of two cases of pseudoprogression in patients with non–small cell lung cancer treated with nivolumab—including histological analysis of one case after tumor regression

Published:2016-12 Issue: Volume:102 Page:44-48
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Tanizaki Junko,Hayashi Hidetoshi,Kimura Masatomo,Tanaka Kaoru,Takeda Masayuki,Shimizu Shigeki,Ito Akihiko,Nakagawa Kazuhiko

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference15 articles.

1. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N. Engl. J. Med.,2015

2. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N. Engl. J. Med.,2015

3. New guidelines to evaluate the response to treatment in solid tumors European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada;Therasse P;J. Natl. Cancer Inst.,2000

4. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1);Eisenhauer EA;Eur. J. Cancer,2009

5. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria;Wolchok;Clin. Cancer Res.,2009

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy outcomes in non-small cell lung cancer patients treated with PD axis inhibitor agents - a population-based study of the Vojvodina region;Pathology and Oncology Research;2024-07-12

2. Symptomatic pseudoprogression in metastatic colorectal cancer;BMJ Case Reports;2024-06

3. Correlation between changes in nutritional status and tumor response in patients receiving immunotherapy for lung cancer (NUTIMMUNO study);Supportive Care in Cancer;2024-04-27

4. An end-to-end weakly supervised learning framework for cancer subtype classification using histopathological slides;Expert Systems with Applications;2024-03

5. Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition;OncoImmunology;2024-02-07